Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
211-225 of 350
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
George Laliotis, MD, MPH, MHA
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Vanessa Helou, MD
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
On the Frontlines of Prostate CancerActive Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Lisa Newcomb, PhD
- advertisement
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
On the Frontlines of Prostate CancerPersonalizing Prostate Cancer Surveillance: Insights from Canary PASS
Lisa Newcomb, PhD
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Deep Breaths: Updates from CHESTEvolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Gerard A. Silvestri MD, MS, Master FCCP
Anurag Singh, MD
Adam H. Fox, MD, MSc
Mariam Alexander, MD, PhD
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Deep Breaths: Updates from CHESTUnderstanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Gerard A. Silvestri MD, MS, Master FCCP
Anurag Singh, MD
Adam H. Fox, MD, MSc
Mariam Alexander, MD, PhD
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Project Oncology®Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Daniel J. George, MD
- advertisement
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Daniel J. George, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Daniel J. George, MD
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Megan Kruse, MD
